Market Update (NYSE:PFE): Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder

[Business Wire] – Pfizer Inc. today announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder treated daily . . . → Read More: Market Update (NYSE:PFE): Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder Similar Articles: Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Completes Acquisition Of InnoPharma Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts